Enhancement- of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions

Neuropsychopharmacology

Volumn 16, Issue 4, 1997, Pages 259-268

  Wan, Rui Qian ^a,b   Corbett, Roy ^a  

^a SANOFI   (France)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Amphetamine; Dopamine D2; DopamineD1; Hippocampus; Locomotion; Neonatal lesions; Neurotoxin

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPHETAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; QUINPIROLE; RACLOPRIDE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; DOPAMINERGIC SYSTEM; FEMALE; HIPPOCAMPUS; LOCOMOTION; NONHUMAN; POSTSYNAPTIC INHIBITION; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0030889422     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(96)00217-5     Document Type: Article

References (56)

1. 2 receptor antagonists fail to differentially alter supersensitive locomotor behavior in the rat. Life Sci 39:1985-1993
2. 3H] dopamine from the rat nucleus accum-bens. Neuropharmacology 29:327-336
3. 2 dopamine receptor interactions. Eur J Pharmacol 123:109-114
4. Beckmann H, Gattaz WF, Jakob H (1987): Biochemical and neuropathological indices for the aetiology of schizophrenia. In Haffiner H, Gattaz WF, Janzarik W (eds), Search for the Causes of Schizophrenia. Springer-Verlag, New York
5. Bloom FE (1993): Advancing a neurodevelopmental origin for schizophrenia. Arch Gen Psychiatry 50:224-227
6. Bogerts B (1993): Recent advances in the neuropathology of schizophrenia. Schizophr Bull 19:431-445
7. Braun AR, Jaskiw GE, Vladar K, Sexton RH, Kolachana BS, Weinberger DR (1993): Effects of ibotenic acid lesions of the medial prefrontal cortex on dopamine agonist-related behaviors in the rat. Pharmacol Biochem Behav 46:51-60
8. Brown R, Colter N, Corsellis JAN, Crow TJ, Frith CD, Jagoe R, Johnstone EC, March L (1986): Postmortem evidence of structural brain changes in schizophrenia: Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry 43:36-42
9. 2 dopamine receptor classification and its functional implications. Synapse 1:347-388
10. 2 dopamine receptors in mediating locomotor activity elicited from the nucleus accumbens of rats. Brain Res 487:267-277
11. 2 agonist quinpirole on locomotion and movements. Eur J Pharmacol 161:151-157
12. 2 dopamine agonists on stereotyped locomotion in rats. Behav Brain Res 45:117-124
13. 2 receptors. Psychopharmacology 106:447-454
14. Falkai P, Bogerts B (1986): Cell loss in the hippocampus of schizophrenics. Eur Arch Psychiatry Neurol Sci 236: 154-161
15. 3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J Neurosci 16:2020-2026
16. 3H]sulpiride. Neurochem Int 7:717-723
17. 3 receptors in rat brain. Eur J Pharmacol 211:189-194
18. Gonzalez-Lima F, Hart WT, Rivera-Quinones C (1987): Metabolite involvement in the behavioral effects of bromocriptine in cats. Eur J Pharmacol 141:109-115
19. Gray JA, Feldon J, Rawlins JNP, Hemsley DR, Smith AD (1991): The neuropsychology of schizophrneia. Behav Brain Sci 14:1-84
20. Groenewegen HJ, Berebdse HW, Meredith GE, Haber SN, Voorn P, Wolters JG, Lohman AHM (1991): Functional anatomy of the ventral, limbic system-innervated striaturn. In Willner P, Scheel-Kruger J (eds), The Mesolimbic Dopamine System: From Motivation to Action. Wiley, Chichester, pp 19-59
21. Hall LD, Herrod JJ, Carpenter TA, McKenna PJ (1994): Magnetic resonance imagine in schizophrenia: A review of clinical and methodological issues. In Ancill RJ, Holliday S, Hihenbottam J (eds), Schizophrenia: Exploring the Spectrum of Psychosis. Wiley, Chichester, pp 115-135
22. Imperato A, Tanda G, Frau R, DiChira G (1988): Pharmacological profile of dopamine receptor agonists as studied by brain dialysis in behaving rats. J Pharmacol Exp Ther 245:257-264
23. Kerwin RW, Murray RM (1992): A developmental perspective on the pathology and neurochemistry of the temporal lobe in schizophrenia. Schizophr Res 7:1-12
24. 4 receptor densities are not altered in rats with neonatal hippocampal damage. Soc Neurosci Abstr 513.3
25. Kotrla KJ, Weinberger DR (1994): A neurodevelopmental perspective on normal brain functioning, plasticity and schizophrenia. In Ancill RJ, Holliday S, Hihenbottam J (eds), Schizophrenia: Exploring the Spectrum of Psychosis. Wiley, Chichester, pp 67-93
26. Lipska BK, Weinberger DR (1993): Delayed effects of neonatal hippocampal damage on haloperidol-induced catelepsy and apomorphine-induced stereotypic behaviors in the rat. Dev Brain Res 75:213-222
27. Lipska BK, Jaskiw GE, Weinberger DR (1993): Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: A potential animal model of schizophrenia. Neuropsychopharmacology 9:67-75
28. Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR (1995a): Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild repeated stress and to chronic haloperidol. Synapse 20:125-130
29. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR (1995b): Neonatal excitotoxic hippocampal damage in rats causes post-pubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 122:35-43
30. MacLennan AJ, Maier SF (1983): Coping and the stress-induced potentiation of stimulant stereotypy in the rat. Science 219:1091-1093
31. McKinney WT, Moran EC (1981): Animal models of schizophrenia. Am J Psychiatry 138:478-483
32. Mednick SA, Cannon TD, Barr CE, Lyon M (1991): Fetal Neural Development and Adult Schizophrenia. Cambridge, Cambridge University Press
33. 2 receptors in the heightened locomotion induced by direct and indirect dopamine agonists in rats with hippocampal damage: An animal analogue of schizophrenia. Behav Brain Res 55:253-267
34. 2 agonist quinpirole on exploratory locomotion. Brain Res 551:216-220
35. 2 dopamine receptor agonists, and the influence of selective antagonists. Pharmacol Biochem Behav 25: 249-253
36. Ojeda SR, Andrews WW, Advis JP, Smith White S (1980): Recent advances in the endocrinology of puberty. Endocrine Rev 1:228-257
37. Paxinos G, Watson C (1986): The rat brain in sterotaxic coordinates, 2nd ed. New York, Acadmic Press
38. Petry N, Furmidge L, Tong Z-Y, Martin C, Clark D (1993): Time sampling observation procedure for studying drug effects: Interaction between d-amphetamine and selective dopamine receptor antagonists in the rat. Pharmacol Biochem Behav 44:167-180
39. Randolph C, Goldberg TE, Weinberger DR (1993): The neuropsychology of schizophrenia. In Heilman KM, Valenstein E (eds) Clinical Neuropsychology, 3rd ed. Oxford, New York, pp 499-522
40. 2 dopamine agonists on turning behavior in rats. Brain Res 384:387-390
41. Schmajuk NA (1987): Animal models for schizophrenia: The hippocampally lesioned animal. Schizophr Bull 13:317-327
42. Seeman P, Van Tol HHM (1994): Dopamine receptor pharmacology. TiPS 15:264-270
43. Totterdell S, Smith AD (1989): Convergence of hippocampal and dopaminergic input onto identified neurons of the nucleus accumbens of the rat. J Chem Neuroanat 2:285-298
44. Van Hartesveldt C, Cottrell GA, Potter T, Meyer ME (1992): Effects of intracerebral quinpirole on locomotion in rats. Eur J Pharmacol 214:27-32
45. Wachtel H, Ahlenius S, Andén N-E (1979): Effects of locally applied dopamine to the nucleus accumbens on the motor activity of normal rats and following α-methyltyrosine reserpine. Psychopharmacology 63:203-206
46. 2 dopamine receptor systems: Their role in the regulation of psychomotor behavior, putative mechanisms, and clinical relevance. J Psychopharmacol 3:54-63
47. 2 agonist effects. Science 236:719-722
48. Wan RQ, Giovanni A, Kafka SH, Corbett R (1996): Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: Behavioral and microdialysis studies. Behav Brain Res 78:211-213
49. 3-receptor: A postsynaptic receptor inhibitory on rat locomotor activity. J Neural Transm 94:11-19
50. 3 receptor antagonists in regard to dopamine release, in vivo receptor displacement and behavior. J Neural Transm 98:39-55
51. Weinberger DR (1987): Implication of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44:660-669
52. Whishaw IQ, Mittleman G (1991): Hippocampal modulation of nucleus accumbens: Behavioral evidence from amphetamine-induced activity profiles. Behav Neural Biol 55: 289-306
53. 2 receptors necessary for the expression of dopamine-mediated behaviors? Pharmacol Biochem Behav 30:189-193
54. Wilkinson LS, Mittleman G, Torres E, Humby T, Hall FS, Robbins TW (1993): Enhancement of amphetamine-induced locomotor activity and dopamine release in nucleus accumbens following excitotoxic lesions of the hippocampus. Behav Brain Res 55:143-150
55. 2 receptor: Role of dopamine in presynaptic inhibition. J Neurosci 6:2470-2478
56. 2 receptor-mediated locomotor activity of conscious rats. Neurosci Let 170:107-110